HEDGEHOG SIGNALING IN RESPONSE TO TISSUE INJURY AND IN NEOPLASIA
响应组织损伤和肿瘤的刺猬信号传导
基本信息
- 批准号:7049167
- 负责人:
- 金额:$ 18.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-12-01 至 2010-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hedgehog (Hh) signaling plays instructive roles in normal embryonic patterning, but pathological pathway
activity in post-embryonic tissues is associated with the growth of tumor types that together account for
approximately 25% of cancer deaths. Normal post-embryonic roles for activation of the Hh signaling
pathway and its sister, the Wnt pathway, have been demonstrated in renewal and maintenance of tissue stem
cells. These findings are of potential relevance to cancer because of the possible derivation of cancer stem
cells, the minority of cells within a cancer that are capable of its propagation, from adult tissue stem cells.
Pathway activity and expansion of progenitor cell pools also are associated with the response to acute
injury, and chronic tissue injury furthermore results in increased risk for cancers of the types associated with
Hh and Wnt pathway activity. Cancer growth thus resembles the activated state of acute injury repair, and
the incidence of cancerous growth increases with the occurrence of repeated injury. These observations
suggest the central hypothesis and several corollaries to be tested in this proposal, namely, that cancer
growth represents the continuous operation of an unregulated state of tissue repair, that continuous Hh
pathway activity in carcinogenesis is a deviation from the return to quiescence that normally follows
regeneration, and that tissue stem cells are the relevant cell types. This hypothesis will be tested in the
context of Hh pathway-dependent cancers by identifying and isolating cancer stem cells, by comparing
these cancer stem cells to each other and to endogenous tissue stem or progenitor cells, and by examining
the role and mechanism of Hh pathway activation in tissue repair and in tumorigenesis. The specific aims
are:
1. To identify and isolate cancer stem cells within established cell lines or primary cell cultures derived
from endodermal tumors that depend upon Hedgehog pathway activity for growth.
2. To identify and isolate candidate stem cells from corresponding resting or injured endodermal organs.
3. To compare the characteristics of cancer stem cells and tissue stem cells from these endodermal organs.
4. To investigate the molecular basis of injury-induced responsiveness to Hh protein signals in normal
tissues and the basis of continuous response in tumors.
These studies will provide a fundamental basis for design and optimization of strategies to manipulate
pathway activity in cancer therapy and in tissue regeneration. An understanding of the mechanistic basis for
regulation of Hh responsiveness also has the potential to foster long-term strategies for cancer prevention.
Hedgehog(Hh)信号在正常胚胎发育中起指导作用,但在病理过程中,
胚胎后组织中的活性与肿瘤类型的生长有关,
大约25%的癌症死亡。Hh信号激活的正常胚胎后作用
Wnt通路及其姊妹通路Wnt通路已被证明在组织茎的更新和维持中起重要作用。
细胞这些发现与癌症有潜在的相关性,因为可能的癌症干细胞的衍生
细胞,癌症中能够增殖的少数细胞,来自成体组织干细胞。
通路活性和祖细胞库的扩增也与急性炎症反应相关。
损伤和慢性组织损伤还导致与癌症相关的类型的癌症的风险增加。
Hh和Wnt途径活性。因此,癌症生长类似于急性损伤修复的激活状态,
随着重复损伤的发生,癌生长的发生率增加。这些观察结果
提出了中心假设和几个推论,以测试在这个建议,即,癌症
生长代表了组织修复的不受调节状态的连续操作,即连续的Hh
在癌发生过程中,通路活动偏离了正常情况下随后的恢复平静,
再生,组织干细胞是相关的细胞类型。这一假设将在
通过识别和分离癌症干细胞,通过比较
这些癌症干细胞相互之间以及与内源性组织干细胞或祖细胞之间的关系,
Hh通路激活在组织修复和肿瘤发生中的作用和机制。具体目标
为:
1.在已建立的细胞系或原代细胞培养物中鉴定和分离癌症干细胞,
从依赖Hedgehog途径活性生长的内胚层肿瘤中分离出来。
2.从相应的静止或损伤的内胚层器官中鉴定和分离候选干细胞。
3.比较肿瘤干细胞和组织干细胞的特性。
4.目的:探讨损伤诱导的正常人对Hh蛋白信号反应性的分子基础。
组织和肿瘤中持续反应的基础。
这些研究将为操纵策略的设计和优化提供基本依据
在癌症治疗和组织再生中的途径活性。理解机械基础,
调节Hh反应性也有可能促进癌症预防的长期战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILIP A BEACHY其他文献
PHILIP A BEACHY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILIP A BEACHY', 18)}}的其他基金
Signal integration by specialized mesenchyme in urothelial homeostasis and Interstitial Cystitis / Bladder Pain Syndrome
尿路上皮稳态和间质性膀胱炎/膀胱疼痛综合征中特殊间充质的信号整合
- 批准号:
10583133 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Salivary gland response to Desert hedgehog signaling as an antidote to damage from therapeutic radiation
唾液腺对沙漠刺猬信号的反应作为治疗辐射损伤的解毒剂
- 批准号:
10420976 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Salivary gland response to Desert hedgehog signaling as an antidote to damage from therapeutic radiation
唾液腺对沙漠刺猬信号的反应作为治疗辐射损伤的解毒剂
- 批准号:
10592398 - 财政年份:2022
- 资助金额:
$ 18.94万 - 项目类别:
Hedgehog signaling in taste cell maintenance and regeneration
味觉细胞维持和再生中的刺猬信号传导
- 批准号:
10394796 - 财政年份:2018
- 资助金额:
$ 18.94万 - 项目类别:
Hedgehog signaling in taste cell maintenance and regeneration
味觉细胞维持和再生中的刺猬信号传导
- 批准号:
9918153 - 财政年份:2018
- 资助金额:
$ 18.94万 - 项目类别:
Hedgehog signaling in taste cell maintenance and regeneration
味觉细胞维持和再生中的刺猬信号传导
- 批准号:
9066827 - 财政年份:2015
- 资助金额:
$ 18.94万 - 项目类别:
Hedgehog signaling in taste cell maintenance and regeneration
味觉细胞维持和再生中的刺猬信号传导
- 批准号:
8954956 - 财政年份:2015
- 资助金额:
$ 18.94万 - 项目类别:
Molecular mechanisms of Hedgehog receptor function
Hedgehog受体功能的分子机制
- 批准号:
8640198 - 财政年份:2012
- 资助金额:
$ 18.94万 - 项目类别:
Molecular mechanisms of Hedgehog receptor function
Hedgehog受体功能的分子机制
- 批准号:
8849924 - 财政年份:2012
- 资助金额:
$ 18.94万 - 项目类别:
相似国自然基金
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
- 批准号:82371631
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
- 批准号:82371150
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于再生运动神经路径优化Agrin作用促进损伤神经靶向投射的功能研究
- 批准号:82371373
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
- 批准号:82371825
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
- 批准号:82370751
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
- 批准号:82371585
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于压力敏感肾单位微流控芯片的肾上皮细胞CAT1-mTOR通路在梗阻性肾损伤中的作用机制研究
- 批准号:82370678
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
运用3D打印和生物反应器构建仿生尿道模型探索Hippo-YAP信号通路调控尿道损伤修复的机制研究
- 批准号:82370684
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
- 批准号:82371301
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
- 批准号:82371152
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
- 批准号:
23K21458 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
- 批准号:
10751760 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Research Grant
Macrophage-polarizing ALMA hydrogels for thyroid regeneration following radiation injury
巨噬细胞极化 ALMA 水凝胶用于放射损伤后甲状腺再生
- 批准号:
MR/Y033817/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Research Grant
Enabling Independent Living for Individuals with Cervical Spinal Cord Injury via High-Density Electromyography Controlled Robotic Systems
通过高密度肌电图控制的机器人系统使颈脊髓损伤患者能够独立生活
- 批准号:
2341352 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Standard Grant
Development of a humanised delivery system for interleukin 2 to treat traumatic brain injury
开发白细胞介素2人源化递送系统来治疗创伤性脑损伤
- 批准号:
MR/X029166/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Research Grant














{{item.name}}会员




